BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25684733)

  • 1. Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem.
    Rahnema CD; Crosnoe LE; Kim ED
    Andrology; 2015 Mar; 3(2):150-5. PubMed ID: 25684733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
    Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
    Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic-androgenic steroids: How do they work and what are the risks?
    Bond P; Smit DL; de Ronde W
    Front Endocrinol (Lausanne); 2022; 13():1059473. PubMed ID: 36644692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of spermatogenesis after androgenic anabolic steroids abuse in men. A systematic review of the literature.
    Rajmil O; Moreno-Sepulveda J
    Actas Urol Esp (Engl Ed); 2024 Mar; 48(2):116-124. PubMed ID: 37567343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the Online Market for Anabolic-Androgenic Steroids in Central Asia: A Netnographic Analysis.
    Nyssanbayeva K; Abdulla V; Semenova Y; Bakasheva M; Sagoe D; Glushkova N
    Subst Use Misuse; 2024; 59(1):10-19. PubMed ID: 37724019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collapsing Glomerulopathy Secondary to Anabolic Steroids for Bodybuilding: A Case Series].
    Passaro R; D'AngiĆ² P; Laurino S; Gigliotti G; Massa A; Mancini A; Gonnella A; Giammarino A; Borriello G
    G Ital Nefrol; 2023 Oct; 40(5):. PubMed ID: 38010246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestatic Jaundice With the Use of Methylstenbolone and Dymethazine, Designer Steroids Found in Super DMZ Rx 2.0 "Nutritional Supplement": A Case Report.
    Agbenyefia P; Arnold CA; Kirkpatrick R
    J Investig Med High Impact Case Rep; 2014; 2(2):2324709614532800. PubMed ID: 26425606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic androgenic steroid abuse in the United Kingdom: An update.
    Mullen C; Whalley BJ; Schifano F; Baker JS
    Br J Pharmacol; 2020 May; 177(10):2180-2198. PubMed ID: 31989581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations of misuse of androgenic anabolic steroids: A retrospective cohort study.
    Heerfordt IM; Windfeld-Mathiasen J; Dalhoff KP; Mogensen M; Andersen JT; Horwitz H
    J Am Acad Dermatol; 2024 May; 90(5):1047-1048. PubMed ID: 38215797
    [No Abstract]   [Full Text] [Related]  

  • 10. Social Media, Body Image and Resistance Training: Creating the Perfect 'Me' with Dietary Supplements, Anabolic Steroids and SARM's.
    Hilkens L; Cruyff M; Woertman L; Benjamins J; Evers C
    Sports Med Open; 2021 Nov; 7(1):81. PubMed ID: 34757466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of recent evidence on androgen abuse from interviews with users.
    Grant B; Minhas S; Jayasena CN
    Curr Opin Endocrinol Diabetes Obes; 2023 Dec; 30(6):285-290. PubMed ID: 37646503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male Fertility After Androgenic Steroid Use: How Little We Know.
    Anawalt BD
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2813-e2815. PubMed ID: 33861859
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination.
    Matusak M; Aljabban J; Wirtz M; Agni R; Spengler E
    Case Reports Hepatol; 2024; 2024():5112461. PubMed ID: 38826497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of seeking an edge: Recurrent renal infarction in setting of recreational use of anabolic steroids.
    Colburn S; Childers WK; Chacon A; Swailes A; Ahmed FM; Sahi R
    Ann Med Surg (Lond); 2017 Feb; 14():25-28. PubMed ID: 28127424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review.
    Solanki P; Eu B; Smith J; Allan C; Lee K
    Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37855241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatotoxicity due to dietary supplements: state-of-the-art, gaps and perspectives.
    Rivero-Pino F; Casanova AG
    Crit Rev Toxicol; 2023 Nov; 53(10):601-610. PubMed ID: 38062980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Quality of Life in Former Androgen Users: An Evolving Public-Health Concern.
    Pope HG; Kanayama G
    J Clin Endocrinol Metab; 2024 Apr; 109(5):e1400-e1401. PubMed ID: 37955864
    [No Abstract]   [Full Text] [Related]  

  • 18. AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects.
    Graham MR; Evans P; Davies B; Baker JS
    Ther Clin Risk Manag; 2008 Jun; 4(3):587-97. PubMed ID: 18827854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dichotomy between health and drug abuse in bodybuilding.
    Horn J
    Nordisk Alkohol Nark; 2024 Apr; 41(2):212-225. PubMed ID: 38645972
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychiatric side effects of medications prescribed in internal medicine.
    Casagrande Tango R
    Dialogues Clin Neurosci; 2003 Jun; 5(2):155-65. PubMed ID: 22034468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.